Pharmacist's Letter | CE & Recommendations You Can Trust

Current Issue

August 2025 Issue

Keep Potential Eye Risks With GLP-1 Agonists in Sight

You’ll see concerns about eye problems with GLP-1 agonists (semaglutide, etc)...

Resources

Chart: GLP-1 and GIP/GLP-1 Receptor Agonist Interactive Comparison Chart

Stay Up to Date on “New” Migraine Meds

You’ll hear buzz about three “new” meds for acute migraine relief...

Put Testosterone Replacement Claims to the Test

Testosterone replacement prescriptions are increasing...

Optimize Treatment for Adults With ADHD

Over 15 million adults in the US have ADHD...

GO TO FULL ISSUE

CE & Training

INTERACTIVE SELF-STUDY CE: Navigating HIV Care: Prevention, Treatment, and Management

CE IN THE LETTER: Pharmacist's Letter August 2025

LIVE CE: Pharmacy Essential Updates August 2025

PODCAST CE: Medication Talk - HIV Prevention: A Guide to PrEP and PEP

GO TO CE & TRAINING ORGANIZER >

Featured Clinical Resources

GLP-1 and GIP/GLP-1 Receptor Agonists interactive chart

Free CE for Pharmacists

Pharmacist's Letter offers ACPE-accredited CE at no charge to help pharmacists meet license renewal requirements. Claim your free CE now:

Group Purchases & Pricing

Pharmacist’s Letter is eligible for bulk discounts. Customize CE and compliance training assignments. Easily manage users and run reports. Bundle with other products for significant savings. Request information